Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Establishment Labs Holdings Inc. (NASDAQ: ESTA) resulting from allegations that Establishment Labs may have issued materially misleading business information to the investing public.
On April 10, 2019, before the market opened, an article entitled, Establishment Labs: Troubling Conflicts And Financial Red Flags was published on Seeking Alpha. This article alleged in part that, [b]ig red flags are apparent in [Establishment Labs] accounting in the form of near-zero product return allowance, extremely high levels of inventory, several going concern clauses, a peripatetic CEO and a physically detached CFO. The article further alleged that Establishment Labs may have supplied the SEC and investors with misleading information. On this news, shares of Establishment Labs dropped sharply during intraday trading.
Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Establishment Labs investors. If you purchased shares of Establishment Labs please visit the firms website at http://www.rosenlegal.com/cases-register-1548.html to join the class action. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
Madison Avenue, 34th Floor
New York, NY 10016
Toll Free: (866) 767-3653
Fax: (212) 202-3827